JAZZ - Jazz Pharmaceuticals plc's (JAZZ) CEO Bruce Cozadd on Q3 2020 Results - Earnings Call Transcript

Jazz Pharmaceuticals plc (JAZZ) Q3 2020 Results Earnings Conference Call November 2, 2020, 4:30 PM ET Company Participants Kathy Littrell - Head, Investor Relations Bruce Cozadd - Chief Executive Officer Renée Galá - Chief Financial Officer Dan Swisher - President Rob Iannone - Executive Vice President, R&D Kim Sablich - Executive Vice President, General Manager, North America Phil Jockelson - Neuroscience Therapeutic Head Ann Borgman - Hematology and Oncology Therapeutic Head Sam Pearce - Senior Vice President, Europe and International Shawn Mindus - Senior Vice President, Strategy and Finance Larry Carter - Global Development Lead, Neuroscience Conference Call Participants Brandon Folkes - Cantor Fitzgerald Umer Raffat - Evercore Gary Nachman - BMO Capital Markets Ami Fadia - SVB Leerink David Amsellem - Piper Sandler Ronny Gal - Bernstein Jason Gerberry - Bank of America Annabel Samimy - Stifel Balaji Prasad - Barclays Akash Tewari - Wolfe Research Gregg Gilbert -

For further details see:

Jazz Pharmaceuticals plc's (JAZZ) CEO Bruce Cozadd on Q3 2020 Results - Earnings Call Transcript